Home    Back

Atomexetine    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
17Multiple system atrophy1

17. Multiple system atrophy    [ 107 clinical trials,   153 drugs,   (DrugBank: 48 drugs),   59 drug target genes,   104 drug target pathways]
Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 107 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02796209
(ClinicalTrials.gov)		May 20167/6/2016Norepinephrine Transporter Blockade, Autonomic FailurePhase 2 Norepinephrine Transporter Blockade, Autonomic FailureMultiple System Atrophy (MSA)Drug: Atomexetine;Drug: PlaceboNYU Langone HealthVanderbilt University Medical CenterRecruiting40 Years80 YearsAll40Phase 2United States